Diagnosed with invasive stage 2 breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Nipples Lymph Nodes Neoplastic Stem Cells Neoplastic Cells, Circulating Epithelial Cells Mammary Glands, Animal

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases46

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Carcinoma Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Lymphatic Metastasis Ovarian Neoplasms Neoplasm Recurrence, Local Fibrocystic Breast Disease Lung Neoplasms Disease Progression Neoplasms Prostatic Neoplasms Bone Neoplasms Carcinoma, Ductal Colonic Neoplasms Carcinoma in Situ Stomach Neoplasms Cell Transformation, Neoplastic Neoplasms, Second Primary Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Adenocarcinoma Pancreatic Neoplasms Fibroadenoma Neoplastic Cells, Circulating Uterine Cervical Neoplasms Neovascularization, Pathologic Neoplasms, Basal Cell Neoplasms, Radiation-Induced Colorectal Neoplasms Endometrial Neoplasms Neoplasms, Multiple Primary Mammary Neoplasms, Animal Lymphedema Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Urinary Bladder Neoplasms Pregnancy Complications, Neoplastic

Chemicals and Drugs57

Protozoan Proteins Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens BRCA2 Protein BRCA1 Protein Aromatase Inhibitors RNA, Messenger Estrogen Antagonists DNA, Neoplasm Estradiol Fluorouracil RNA, Small Interfering Antibodies, Monoclonal, Humanized Cyclophosphamide Estrogen Receptor Modulators Epirubicin Selective Estrogen Receptor Modulators Nitriles Tumor Suppressor Protein p53 Antibodies, Monoclonal Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Paclitaxel Ki-67 Antigen RNA, Neoplasm Cancer Vaccines Antigens, Neoplasm Anticarcinogenic Agents Antigens, CD24 Triazoles Mucin-1 Transcription Factors Anthracyclines MicroRNAs Antibiotics, Antineoplastic DNA-Binding Proteins Proto-Oncogene Proteins c-akt Cyclin D1 Doxorubicin Progestins Proto-Oncogene Proteins Nuclear Proteins Methotrexate Deoxycytidine Cadherins Protein-Serine-Threonine Kinases Cisplatin Quinazolines Antineoplastic Agents, Phytogenic

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Mammography Prognosis Neoplasm Staging Early Detection of Cancer Mastectomy Risk Factors Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Survival Analysis Case-Control Studies Breast Self-Examination Mammary Neoplasms, Experimental Disease-Free Survival Risk Gene Expression Profiling Immunohistochemistry Follow-Up Studies Survival Rate Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Risk Assessment Retrospective Studies Mastectomy, Segmental Odds Ratio Incidence Treatment Outcome Xenograft Model Antitumor Assays Blotting, Western Cohort Studies Multivariate Analysis Registries Sensitivity and Specificity Ultrasonography, Mammary Neoplasm Transplantation Transplantation, Heterologous Oligonucleotide Array Sequence Analysis SEER Program Tissue Array Analysis Questionnaires Kaplan-Meier Estimate Predictive Value of Tests Logistic Models Tumor Burden Breast Implants Combined Modality Therapy Reproducibility of Results Mass Screening Neoplasm Grading Transfection Radiotherapy, Adjuvant Polymerase Chain Reaction Mammaplasty Confidence Intervals Immunoenzyme Techniques Clinical Trials as Topic Neoadjuvant Therapy Genetic Testing Drug Screening Assays, Antitumor Proportional Hazards Models Molecular Targeted Therapy Drug Administration Schedule Sentinel Lymph Node Biopsy Radiotherapy Biopsy, Needle Estrogen Replacement Therapy Gene Knockdown Techniques Lymph Node Excision Biopsy In Situ Hybridization, Fluorescence Mastectomy, Radical Models, Biological DNA Mutational Analysis Reproductive History Hormone Replacement Therapy

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Genes, BRCA1 Postmenopause Genetic Predisposition to Disease Breast Feeding Premenopause Drug Resistance, Neoplasm Risk Cell Proliferation Menopause Genes, BRCA2 Genes, erbB-2 Odds Ratio Mutation Apoptosis Signal Transduction Time Factors Sensitivity and Specificity Cell Movement Cell Division Genotype Germ-Line Mutation Down-Regulation Polymorphism, Genetic DNA Methylation Promoter Regions, Genetic Cell Growth Processes Gene Amplification Transfection Cell Cycle RNA Interference Dose-Response Relationship, Drug Parity Up-Regulation Gene Silencing Cell Survival Gene Expression Genes, Tumor Suppressor Phenotype Genes, Neoplasm Phosphorylation Base Sequence Epithelial-Mesenchymal Transition Genes, p53 Alleles Diet Heterozygote Drug Synergism Polymorphism, Single Nucleotide Transcription, Genetic Tumor Microenvironment

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care35

Risk Factors Survival Analysis Case-Control Studies Disease-Free Survival Risk Follow-Up Studies Survival Rate Prospective Studies Risk Assessment Age Factors Retrospective Studies Odds Ratio Incidence Treatment Outcome Cohort Studies Multivariate Analysis Registries Sensitivity and Specificity SEER Program Questionnaires Kaplan-Meier Estimate Predictive Value of Tests Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Clinical Trials as Topic Parity Genetic Testing Proportional Hazards Models National Cancer Institute (U.S.)Age of Onset Reproductive History Family Health Genetic Counseling

Geographicals3

United States China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Protozoan Proteins Breast Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen Cell Line, Tumor Breast Diseases Receptor, erbB-2 Tamoxifen Receptors, Progesterone Mammography Gene Expression Regulation, Neoplastic Neoplasm Metastasis Neoplasm Invasiveness Prognosis Tumor Markers, Biological Breast Neoplasms, Male Antineoplastic Agents, Hormonal Neoplasm Staging Early Detection of Cancer Mastectomy Risk Factors Genes, BRCA1 Antineoplastic Agents Neoplasm Proteins Postmenopause Chemotherapy, Adjuvant Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating MCF-7 Cells Mice, Nude Genetic Predisposition to Disease Breast Feeding Premenopause Tumor Cells, Cultured Antineoplastic Combined Chemotherapy Protocols Estrogen Receptor alpha Survival Analysis Drug Resistance, Neoplasm Case-Control Studies Estrogens Carcinoma Breast Self-Examination Mammary Neoplasms, Experimental Disease-Free Survival Neoplasms, Hormone-Dependent Risk Gene Expression Profiling Lymphatic Metastasis Ovarian Neoplasms Cell Proliferation Immunohistochemistry Follow-Up Studies Neoplasm Recurrence, Local Menopause BRCA2 Protein Survival Rate Genes, BRCA2 BRCA1 Protein Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Fibrocystic Breast Disease Aromatase Inhibitors RNA, Messenger Risk Assessment Estrogen Antagonists Lung Neoplasms Survivors Age Factors Retrospective Studies Mastectomy, Segmental Axilla Disease Progression Genes, erbB-2 Odds Ratio Neoplasms Incidence Mammary Glands, Human Prostatic Neoplasms Treatment Outcome DNA, Neoplasm Xenograft Model Antitumor Assays Mutation Blotting, Western Cohort Studies Multivariate Analysis Estradiol Apoptosis Signal Transduction Fluorouracil RNA, Small Interfering Registries United States Bone Neoplasms Time Factors Sensitivity and Specificity Ultrasonography, Mammary Antibodies, Monoclonal, Humanized Neoplasm Transplantation Cell Movement

No FAQ available that match "diagnosed with invasive stage 2 breast cancer"